Tenascin-C increases lung metastasis by impacting blood vessel invasions.
Animals
Blood Vessels
/ metabolism
Cell Line, Tumor
Female
Gene Knockout Techniques
Humans
Lung Neoplasms
/ blood supply
Mammary Neoplasms, Experimental
/ blood supply
Mice
Mice, Transgenic
Rats
Receptor, ErbB-2
/ genetics
Signal Transduction
Stromal Cells
Tenascin
/ genetics
Transforming Growth Factor beta
/ metabolism
Blood vessel invasions
Cellular plasticity
Circulating tumor cells
Endothelial cells
Endothelialization
Fsp1+ cells
Lung metastasis
TGF-β signaling
Tenascin-C
Tumor emboli
Journal
Matrix biology : journal of the International Society for Matrix Biology
ISSN: 1569-1802
Titre abrégé: Matrix Biol
Pays: Netherlands
ID NLM: 9432592
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
27
03
2019
revised:
30
05
2019
accepted:
02
07
2019
pubmed:
10
7
2019
medline:
12
5
2020
entrez:
10
7
2019
Statut:
ppublish
Résumé
Metastasis is a major cause of death in cancer patients. The extracellular matrix molecule tenascin-C is a known promoter of metastasis, however the underlying mechanisms are not well understood. To further analyze the impact of tenascin-C on cancer progression we generated MMTV-NeuNT mice that develop spontaneous mammary tumors, on a tenascin-C knockout background. We also developed a syngeneic orthotopic model in which tumor cells derived from a MMTV-NeuNT tumor. Tumor cells were transfected with control shRNA or with shRNA to knockdown tenascin-C expression and, were grafted into the mammary gland of immune competent, wildtype or tenascin-C knockout mice. We show that stromal-derived tenascin-C increases metastasis by reducing apoptosis and inducing the cellular plasticity of cancer cells located in pulmonary blood vessels invasions (BVI), before extravasation. We characterized BVI as organized structures of tightly packed aggregates of proliferating tumor cells with epithelial characteristics, surrounded by Fsp1+ cells, internally located platelets and, a luminal monolayer of endothelial cells. We found extracellular matrix, in particular, tenascin-C, between the stromal cells and the tumor cell cluster. In mice lacking stromal-derived tenascin-C, the organization of pulmonary BVI was significantly affected, revealing novel functions of host-derived tenascin-C in supporting the integrity of the endothelial cell coat, increasing platelet abundance, tumor cell survival, epithelial plasticity, thereby promoting overall lung metastasis. Many effects of tenascin-C observed in BVI including enhancement of cellular plasticity, survival and migration, could be explained by activation of TGF-β signaling. Finally, in several human cancers, we also observed BVI to be surrounded by an endothelial monolayer and to express tenascin-C. Expression of tenascin-C is specific to BVI and is not observed in lymphatic vascular invasions frequent in breast cancer, which lack an endothelial lining. Given that BVI have prognostic significance for many tumor types, such as shorter cancer patient survival, increased metastasis, vessel occlusion, and organ failure, our data revealing a novel mechanism by which stromal tenascin-C promotes metastasis in human cancer, may have potential for diagnosis and therapy.
Identifiants
pubmed: 31288084
pii: S0945-053X(19)30128-3
doi: 10.1016/j.matbio.2019.07.001
pii:
doi:
Substances chimiques
Tenascin
0
Tnc protein, mouse
0
Transforming Growth Factor beta
0
Erbb2 protein, rat
EC 2.7.10.1
Receptor, ErbB-2
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
26-47Subventions
Organisme : Versus Arthritis
ID : 20003
Pays : United Kingdom
Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.